endo-BCN-PEG4-Val-Cit-PAB-MMAF
PG-20161-16815
Product information
- Catalog No.
- PG-20161-16815
- Product Name
- endo-BCN-PEG4-Val-Cit-PAB-MMAF
- CAS No.
- Not specified
- Molecular Formula
- C80H125N11O20
- Molecular Weight
- 1560.9
- Purity
- 90%
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-16815 | 5 MG | Inquiry | In stock | |
| PG-20161-16815 | 10 MG | Inquiry | In stock | |
| PG-20161-16815 | 25 MG | Inquiry | In stock | |
| PG-20161-16815 | 50 MG | Inquiry | In stock |
Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- endo-BCN-PEG4-Val-Cit-PAB-MMAF
- CAS No.
- Not specified
- Synonyms
- Not specified
- Molecular Formula
- C80H125N11O20
- Molecular Weight
- 1560.9
- Appearance
- Not specified
- Solubility
- Not specified
- Description
endo-BCN-PEG4-Val-Cit-PAB-MMAF is an antibody-drug conjugate (ADC) precursor combining a BCN group, a protease-sensitive Val-Cit dipeptide and an MMAF payload. The BCN group enables copper-free click coupling with azide-tagged molecules, supporting its use as a click chemistry reagent.
MMAF is described as a synthetic antineoplastic agent. This precursor is used in constructing monoclonal antibody conjugates and is cataloged among cleavable ADC linkers and MMAF payload reagents.